For most adults with diabetes, the broadly accepted blood sugar targets are 80 to 130 mg/dL before meals and below 180 mg/dL one to two hours after a meal, with an HbA1c goal of around 7%. Those numbers come from major diabetes organizations and have been shaped by decades of clinical trial evidence, but they are starting points, not fixed rules. Your actual targets may be tighter or looser depending on the type of diabetes you have, your age, how long you’ve been living with the condition, and whether you’re pregnant or managing other health issues.
Where the Standard Targets Come From
The reason the 7% HbA1c threshold is so widely cited traces back to two landmark trials. The Diabetes Control and Complications Trial (DCCT) in type 1 diabetes showed that keeping HbA1c around 7% instead of around 9% produced a 50 to 76% reduction in the development and progression of complications affecting the eyes, kidneys, and nerves.1Diabetes Care. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2022 The UK Prospective Diabetes Study (UKPDS) confirmed a similar benefit for people with type 2 diabetes. Those findings cemented HbA1c below 7% as the standard goal. However, neither trial identified a safe lower cutoff where complications kept dropping without hypoglycemia risk climbing in tandem.2Journal of Diabetes Mellitus. Evolution of Glycemic Targets in Management of Diabetes
That tension between “lower is better for complications” and “too low causes its own harm” is the reason targets are individualized rather than universal. A later large trial, the ADVANCE study, tested intensive glucose control aiming for an HbA1c of 6.5% versus standard control at 7.3% in people with type 2 diabetes. After about five years, the intensive group saw fewer combined vascular events and less kidney disease, but there was no significant reduction in heart attacks, cardiovascular death, or death from any cause.3PubMed. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes So pushing below 7% does buy some additional protection against certain complications, but the payoff shrinks and the risks grow.
What the Day-to-Day Numbers Mean
HbA1c reflects your average blood sugar over roughly two to three months, but it doesn’t tell you much about what happens hour to hour. Two people can have the same HbA1c and very different daily patterns: one may cruise along with steady readings, while the other swings between highs and lows that average out to the same number. That’s why day-to-day blood sugar checks still matter.
The commonly recommended pre-meal target of 80 to 130 mg/dL and the post-meal target of under 180 mg/dL are designed to keep you in a zone that minimizes both short-term symptoms and long-term damage. After eating, blood sugar naturally rises; the question is how high and for how long. In someone without diabetes, levels rarely exceed about 140 mg/dL after a meal and return to baseline fairly quickly. In diabetes, the goal isn’t to perfectly replicate that non-diabetic curve but to stay close enough that the body’s tissues aren’t constantly bathed in excess glucose.
Time in Range and Continuous Glucose Monitors
If you use a continuous glucose monitor (CGM), you’ve probably encountered the phrase “time in range,” often abbreviated TIR. This metric captures the percentage of time your blood sugar stays between 70 and 180 mg/dL (3.9 to 10 mmol/L) over a given period. The international consensus recommendation is to spend more than 70% of the day in that range, which works out to roughly 16 hours and 48 minutes.4PubMed Central. Time in range—A new gold standard in type 2 diabetes research?
CGM data also highlights the extremes. Time above range is split into two tiers: readings over 180 mg/dL and readings over 250 mg/dL, with the latter being a red flag that urgent correction is needed. Time below range is similarly divided: readings between 54 and 69 mg/dL signal risk of low blood sugar, while anything under 54 mg/dL is clinically dangerous and should account for less than 1% of the day.5PubMed. Positioning time in range in diabetes management For older adults or people at high risk of hypoglycemia, the TIR target is relaxed to above 50% of the day, which is about 12 hours.4PubMed Central. Time in range—A new gold standard in type 2 diabetes research?
CGMs measure glucose in the fluid just beneath the skin rather than directly in the blood, so readings can lag behind a finger-stick measurement by several minutes, especially during rapid changes. Early evaluations of continuous monitors found that the average difference between the sensor and a finger-stick was small, less than about 1.2 mmol/L in real-world home use, but the lag can matter when blood sugar is dropping fast.6PubMed. Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes Modern sensors have improved considerably since those early devices, but the principle remains: if you feel low, trust the feeling and treat it rather than waiting for the sensor to catch up.
How Type 1 and Type 2 Diabetes Differ in Practice
The official blood sugar targets are largely the same for type 1 and type 2 diabetes, but the day-to-day experience of hitting those targets is very different. In type 1 diabetes, blood sugar tends to swing more dramatically because the body produces essentially no insulin on its own. Continuous monitoring data shows that people with type 1 diabetes experience roughly twice as many hypoglycemic episodes per day compared with those who have type 2, and those episodes last longer on average, about 1.1 hours versus 0.7 hours per episode.7Diabetes Care. Glycemic Characteristics in Continuously Monitored Patients With Type 1 and Type 2 Diabetes: Normative values
This is one reason why the consensus guidelines for time below range are particularly careful for type 1 diabetes: less than 4% of the day below 70 mg/dL and less than 1% below 54 mg/dL.5PubMed. Positioning time in range in diabetes management The targets look the same on paper for both types, but achieving them in type 1 requires more frequent adjustments, more careful carbohydrate counting, and a greater tolerance for the fact that perfection is elusive.
Blood Sugar Targets During Pregnancy
Pregnancy changes everything about blood sugar management. The developing fetus is sensitive to glucose, and even moderately elevated maternal blood sugar raises the risk of complications for both mother and baby. Targets during pregnancy are considerably tighter than the usual ranges. Guidelines generally call for fasting levels under 95 mg/dL, one-hour post-meal levels under 140 mg/dL, and two-hour post-meal levels under 120 mg/dL.
These tight targets are achievable but demanding. Early work on maintaining near-normal glucose in insulin-dependent pregnant women showed that plasma glucose could be kept in the 60 to 140 mg/dL range, averaging around 80 mg/dL, throughout pregnancy with intensive monitoring and insulin adjustment.8The American Journal of Medicine. Feasibility of maintaining normal glucose profiles in insulin-dependent pregnant diabetic women The feasibility has improved since then with better insulin analogs and CGMs, but it still requires frequent daily checks and a willingness to fine-tune doses on the fly.
Gestational diabetes, the kind that appears during pregnancy in women who weren’t previously diabetic, typically uses the same tight targets. Most women manage it with dietary changes and exercise; some require insulin. Blood sugar usually returns to normal after delivery, though having gestational diabetes increases the long-term risk of developing type 2 diabetes later in life.
When Blood Sugar Drops Too Low
Hypoglycemia is generally defined as blood sugar below 70 mg/dL, with readings under 54 mg/dL considered clinically serious. But the symptoms you feel don’t always line up neatly with a specific number on your meter. The body’s warning signals, things like shakiness, sweating, pounding heart, and hunger, are triggered by the autonomic nervous system’s response to dropping glucose. If glucose keeps falling, the brain itself starts to starve, producing confusion, weakness, and in severe cases seizures or loss of consciousness.9PubMed. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness
Here’s a wrinkle that catches many people off guard: the blood sugar level at which you start feeling low isn’t fixed. In people whose diabetes has been poorly controlled, with average readings running high for months, symptoms of hypoglycemia can kick in at surprisingly higher levels. One study found that the threshold for hypoglycemia symptoms averaged about 78 mg/dL in patients with poorly controlled diabetes, compared with about 53 mg/dL in people without diabetes.10PubMed. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics The opposite can also happen: frequent lows cause the body to stop sounding the alarm, a condition called hypoglycemia unawareness. In that case, you may feel fine at 55 mg/dL and miss the window to treat the drop before it becomes dangerous.9PubMed. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness
When Blood Sugar Spikes Dangerously High
On the other end of the spectrum, blood sugar above 250 mg/dL is where acute danger begins to enter the picture. In type 1 diabetes especially, sustained highs combined with insulin deficiency can trigger diabetic ketoacidosis (DKA), a condition in which the body breaks down fat at a dangerous rate and the blood becomes acidic. A recent consensus report lowered the glucose threshold for considering DKA from above 250 mg/dL to 200 mg/dL or higher, paired with elevated ketones and metabolic acidosis, because some people develop DKA at glucose levels that aren’t astronomically high.11Diabetes Care. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report
In type 2 diabetes, the equivalent emergency is hyperosmolar hyperglycemic state (HHS), which typically involves blood sugar readings well above 600 mg/dL and severe dehydration. HHS develops more slowly than DKA and is more common in older adults, sometimes triggered by an illness that prevents adequate fluid intake. Both DKA and HHS are medical emergencies. If your meter reads above 300 mg/dL and you feel sick, checking for ketones and seeking medical attention quickly is important.
The Dawn Phenomenon
If you’ve ever woken up with high fasting blood sugar despite going to bed with a perfectly reasonable reading, you’ve probably experienced the dawn phenomenon. In the early-morning hours, the body releases a surge of hormones, including cortisol and growth hormone, that tell the liver to push out glucose. In someone without diabetes, insulin output rises to match. In diabetes, that compensation doesn’t happen effectively, and blood sugar climbs before breakfast. Roughly half of all people with diabetes experience this: one review found the dawn phenomenon in about 54% of people with type 1 and 55% with type 2 diabetes.12ScienceDirect (Endocrine Practice). The Dawn Phenomenon Revisited: Implications for Diabetes Therapy
This is worth knowing because a high fasting reading can be discouraging and confusing when you feel like you “did everything right” the night before. The dawn phenomenon is a hormonal pattern, not a failure of willpower. Solutions include adjusting overnight insulin timing, using a long-acting insulin formulation with a flatter profile, or, for some people with type 2 diabetes, a bedtime dose of metformin. If your fasting numbers consistently run 30 or 40 mg/dL above your target, it’s worth discussing with your care team rather than just assuming you ate too much at dinner.
Stress, Steroids, and Illness
Physical and emotional stress both raise blood sugar, often dramatically. During illness, surgery, or emotional upheaval, the body’s stress response dumps cortisol and adrenaline into the bloodstream, which in turn tells the liver to release stored glucose. This stress-induced hyperglycemia isn’t just inconvenient: it’s linked to worse outcomes in hospitalized patients, including higher mortality, even in people who didn’t have a diabetes diagnosis before being admitted.13Endocrinology and Metabolism. Glucocorticoid-Induced Hyperglycemia: A Neglected Problem
Steroid medications like prednisone and dexamethasone are among the most common culprits for unexpectedly high blood sugar. They can worsen control in people who already have diabetes, unmask previously undiagnosed diabetes, or cause new-onset “steroid diabetes” in people who were otherwise healthy.14PubMed Central. Management of Glucocorticoid-Induced Hyperglycemia If you’re prescribed a steroid course for asthma, a joint flare, or another inflammatory condition, expect your blood sugar to run higher than usual, sometimes much higher, and talk to your prescriber about adjusting your diabetes medications for the duration.
Sleep, Shift Work, and Glucose Control
Disrupted sleep and irregular schedules can throw blood sugar control off in ways that are easy to overlook. Research into night-shift workers has shown that insufficient sleep and disruption of the normal sleep-wake cycle reduce the body’s response to insulin and impair glucose processing.15PubMed Central. Unraveling the complex relationship between night shift work and diabetes: exploring mechanisms and potential interventions If you rotate between day and night shifts, you may find your blood sugar less predictable on days following a night shift. A study of healthcare workers with type 2 diabetes who wore CGMs found that certain measures of glucose variability were higher during and after night shifts compared with days off, even though average glucose levels were similar.16PubMed Central. Characterising the impact of shift work on diet and glucose variability in healthcare employees living with type 2 diabetes: The Shift-Diabetes study
In practical terms, that means the same meal eaten at 2 a.m. during a night shift may produce a larger or less predictable blood sugar spike than the same meal eaten at noon. This doesn’t mean shift work makes diabetes unmanageable, but it does mean you may need to check more frequently and expect more variability rather than assuming something is wrong with your medication.
Walking After Meals
One of the simplest tools for managing post-meal blood sugar is a short walk. Research on people with type 1 diabetes found that walking after a meal cut the post-meal blood sugar spike roughly in half compared with sitting still. The difference between peak and baseline glucose was about 6.4 mmol/L on walking days versus 14.4 mmol/L on sedentary days.17PubMed. A Study Examining the Effect of a Short Bout of Postprandial Walking on the Glycemic Effect of a Meal: Type 1 Diabetes That’s a meaningful difference, and it doesn’t require a gym session. Even ten minutes of light walking immediately after eating appears to be effective, and evidence suggests that walking sooner after a meal works better than waiting 30 minutes.18Scientific Reports. Positive impact of a 10-min walk immediately after glucose intake on postprandial glucose levels
This doesn’t replace medication, but it’s a free, accessible way to blunt the highest spikes, especially after a carbohydrate-heavy meal. For people who struggle to keep post-meal readings under 180 mg/dL despite medication adjustments, a brief walk is worth trying before adding or increasing drugs.
When HbA1c Results Can Be Misleading
HbA1c is the workhorse lab test for gauging overall glucose control, but it has real limitations. The test measures how much glucose is attached to hemoglobin in your red blood cells, and because red blood cells live for about three months, HbA1c reflects an average over that window. Anything that changes the lifespan or structure of red blood cells can skew the result. Conditions like iron-deficiency anemia, sickle cell trait, recent blood transfusions, chronic kidney disease, and even certain hemoglobin variants can push HbA1c artificially higher or lower than your true average blood sugar.19PubMed Central. Pitfalls in hemoglobin A1c measurement: when results may be misleading
If your HbA1c seems inconsistent with your daily meter or CGM readings, the discrepancy could be physiological rather than a sign that you’re measuring wrong. Your doctor can order alternative markers like fructosamine, which reflects average glucose over the past two to three weeks and isn’t affected by hemoglobin issues. For anyone with a known hemoglobin variant or chronic anemia, relying solely on HbA1c for treatment decisions can lead to undertreating or overtreating diabetes.
Why Guidelines Vary Around the World
If you’ve looked up blood sugar targets from different countries, you may have noticed they don’t all agree. A comparison of national diabetes guidelines from non-Western countries found that most relied heavily on American Diabetes Association standards, with about 55% referencing ADA guidance and 36% drawing on International Diabetes Federation recommendations.20PubMed Central. Comparison of National/Regional Diabetes Guidelines for the Management of Blood Glucose Control in non-Western Countries The underlying evidence is the same handful of large clinical trials, but different countries weigh local factors like healthcare access, diet composition, and prevalence of specific complications differently.
In practice, the differences tend to be small: one guideline might set the HbA1c target at below 7% while another uses below 6.5% for newly diagnosed patients or below 8% for older adults with multiple health issues. The broader principle is consistent across guidelines: tighter control reduces microvascular complications, but the benefit plateaus and the risk of dangerous lows increases as you push toward the lower end. The “right” target is always a negotiation between the theoretical ideal and what you can achieve safely in your real life.